Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.
Abd El Bary, N., Maher, M., Elsherbini, M., Abdeen, M., Hashem, T. (2019). Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.. EKB Journal Management System, 15(1), 38-38. doi: 10.21608/resoncol.2018.6131.1067
Naser Abd El Bary; Mina Maher; Mohamed Elsherbini; Mohamed Abdeen; Tarek Hashem. "Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.". EKB Journal Management System, 15, 1, 2019, 38-38. doi: 10.21608/resoncol.2018.6131.1067
Abd El Bary, N., Maher, M., Elsherbini, M., Abdeen, M., Hashem, T. (2019). 'Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.', EKB Journal Management System, 15(1), pp. 38-38. doi: 10.21608/resoncol.2018.6131.1067
Abd El Bary, N., Maher, M., Elsherbini, M., Abdeen, M., Hashem, T. Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.. EKB Journal Management System, 2019; 15(1): 38-38. doi: 10.21608/resoncol.2018.6131.1067

Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.

Research in Oncology
Article 8, Volume 15, Issue 1, June 2019, Page 38-38  XML PDF (11.74 K)
Document Type: Errartum
DOI: 10.21608/resoncol.2018.6131.1067
View on SCiNiTO View on SCiNiTO
Authors
Naser Abd El Bary email 1; Mina Maher1; Mohamed Elsherbiniorcid 1; Mohamed Abdeen2; Tarek Hashem1
1Clinical Oncology Department, Faculty of Medicine, Menoufia University, Shibin El-Kom, Egypt
2Clinical Oncology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
Abstract
This corrigendum corrects the author list and affiliations of the article: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.
In response to a request supported by documents from the corresponding author, the name Dr. Mohamed Elsherbini was added to the list of authors and the affiliation of Dr. Mohamed Abdeen was mentioned.
The corrected version of this article replaces the primarily published one.
Keywords
Corrigendum; Abd El Bary et al; Kasr El-Aini J Clin Oncol Nucl Med 2009
Statistics
Article View: 583
PDF Download: 476